chr6-32062138-G-T
Variant names:
Variant summary
Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2
The NM_001365276.2(TNXB):c.7168+19C>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00521 in 1,604,262 control chromosomes in the GnomAD database, including 103 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Genomes: 𝑓 0.0048 ( 4 hom., cov: 32)
Exomes 𝑓: 0.0052 ( 99 hom. )
Consequence
TNXB
NM_001365276.2 intron
NM_001365276.2 intron
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.181
Publications
1 publications found
Genes affected
TNXB (HGNC:11976): (tenascin XB) This gene encodes a member of the tenascin family of extracellular matrix glycoproteins. The tenascins have anti-adhesive effects, as opposed to fibronectin which is adhesive. This protein is thought to function in matrix maturation during wound healing, and its deficiency has been associated with the connective tissue disorder Ehlers-Danlos syndrome. This gene localizes to the major histocompatibility complex (MHC) class III region on chromosome 6. It is one of four genes in this cluster which have been duplicated. The duplicated copy of this gene is incomplete and is a pseudogene which is transcribed but does not encode a protein. The structure of this gene is unusual in that it overlaps the CREBL1 and CYP21A2 genes at its 5' and 3' ends, respectively. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2008]
TNXB Gene-Disease associations (from GenCC):
- Ehlers-Danlos syndromeInheritance: AR Classification: DEFINITIVE Submitted by: G2P
- Ehlers-Danlos syndrome due to tenascin-X deficiencyInheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Genomics England PanelApp, Illumina, PanelApp Australia, Orphanet
- familial vesicoureteral refluxInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- vesicoureteral reflux 8Inheritance: AD Classification: LIMITED Submitted by: Labcorp Genetics (formerly Invitae)
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.84).
BP6
Variant 6-32062138-G-T is Benign according to our data. Variant chr6-32062138-G-T is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 261153.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population sas. GnomAd4 allele frequency = 0.00484 (737/152310) while in subpopulation SAS AF = 0.0135 (65/4830). AF 95% confidence interval is 0.0108. There are 4 homozygotes in GnomAd4. There are 397 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 4 AR,AD gene
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| TNXB | NM_001365276.2 | c.7168+19C>A | intron_variant | Intron 20 of 43 | ENST00000644971.2 | NP_001352205.1 | ||
| TNXB | NM_001428335.1 | c.7909+19C>A | intron_variant | Intron 21 of 44 | NP_001415264.1 | |||
| TNXB | NM_019105.8 | c.7168+19C>A | intron_variant | Intron 20 of 43 | NP_061978.6 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| TNXB | ENST00000644971.2 | c.7168+19C>A | intron_variant | Intron 20 of 43 | NM_001365276.2 | ENSP00000496448.1 | ||||
| TNXB | ENST00000647633.1 | c.7909+19C>A | intron_variant | Intron 21 of 44 | ENSP00000497649.1 | |||||
| TNXB | ENST00000375244.7 | c.7168+19C>A | intron_variant | Intron 20 of 43 | 5 | ENSP00000364393.3 |
Frequencies
GnomAD3 genomes AF: 0.00485 AC: 738AN: 152192Hom.: 4 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
738
AN:
152192
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.00646 AC: 1545AN: 239338 AF XY: 0.00717 show subpopulations
GnomAD2 exomes
AF:
AC:
1545
AN:
239338
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00525 AC: 7619AN: 1451952Hom.: 99 Cov.: 32 AF XY: 0.00564 AC XY: 4068AN XY: 720708 show subpopulations
GnomAD4 exome
AF:
AC:
7619
AN:
1451952
Hom.:
Cov.:
32
AF XY:
AC XY:
4068
AN XY:
720708
show subpopulations
African (AFR)
AF:
AC:
69
AN:
33262
American (AMR)
AF:
AC:
209
AN:
44226
Ashkenazi Jewish (ASJ)
AF:
AC:
764
AN:
25808
East Asian (EAS)
AF:
AC:
1569
AN:
39460
South Asian (SAS)
AF:
AC:
1017
AN:
85406
European-Finnish (FIN)
AF:
AC:
36
AN:
52178
Middle Eastern (MID)
AF:
AC:
131
AN:
5734
European-Non Finnish (NFE)
AF:
AC:
3432
AN:
1105878
Other (OTH)
AF:
AC:
392
AN:
60000
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.496
Heterozygous variant carriers
0
446
893
1339
1786
2232
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
158
316
474
632
790
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.00484 AC: 737AN: 152310Hom.: 4 Cov.: 32 AF XY: 0.00533 AC XY: 397AN XY: 74482 show subpopulations
GnomAD4 genome
AF:
AC:
737
AN:
152310
Hom.:
Cov.:
32
AF XY:
AC XY:
397
AN XY:
74482
show subpopulations
African (AFR)
AF:
AC:
62
AN:
41574
American (AMR)
AF:
AC:
100
AN:
15302
Ashkenazi Jewish (ASJ)
AF:
AC:
87
AN:
3468
East Asian (EAS)
AF:
AC:
69
AN:
5182
South Asian (SAS)
AF:
AC:
65
AN:
4830
European-Finnish (FIN)
AF:
AC:
5
AN:
10616
Middle Eastern (MID)
AF:
AC:
6
AN:
294
European-Non Finnish (NFE)
AF:
AC:
329
AN:
68016
Other (OTH)
AF:
AC:
14
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.496
Heterozygous variant carriers
0
41
82
123
164
205
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
39
AN:
3478
ClinVar
Significance: Benign/Likely benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:3
Jul 09, 2018
GeneDx
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
May 24, 2017
Center for Pediatric Genomic Medicine, Children's Mercy Hospital and Clinics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
not specified Benign:1
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.